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Peptide-MHC (pMHC) ligand engagement by T-cell receptors (TCRs) elicits a variety of cel-
lular responses, some of which require substantially more TCR-mediated stimulation than
others.This threshold hierarchy could reside at the receptor level, where different response
pathways branch off at different stages of the TCR/CD3 triggering cascade, or at the cellu-
lar level, where the cumulative TCR signal registered by the T-cell is compared to different
threshold values. Alternatively, dual-level thresholds could exist. In this study, we show
that the cellular hypothesis provides the most parsimonious explanation consistent with
data obtained from an in-depth analysis of distinct functional responses elicited in a clonal
T-cell system by a spectrum of biophysically defined altered peptide ligands across a range
of concentrations. Further, we derive a mathematical model that describes how ligand
density, affinity, and off-rate all affect signaling in distinct ways. However, under the kinetic
regime prevailing in the experiments reported here, the TCR/pMHC class I (pMHCI) dis-
sociation rate was found to be the main governing factor. The CD8 coreceptor modulated
the TCR/pMHCI interaction and altered peptide ligand potency. Collectively, these find-
ings elucidate the relationship betweenTCR/pMHCI kinetics and cellular function, thereby
providing an integrated mechanistic understanding of T-cell response profiles.
Keywords:T-cell activation,T-cell cross-reactivity,T-cell receptor
INTRODUCTION
T lymphocyte antigen receptors mediate adaptive immune
responses via interactions with disease-associated peptide ligands
presented on the surface of target cells by major histocompatibility
complex (MHC) molecules. In the case of CD8+ T-lymphocytes
(CTLs), which constitute the classical T-cell effector subset, the
clonotypically expressed T-cell receptors (TCRs) engage spe-
cific peptide-MHC class I (pMHCI) molecules to elicit several
functions that are instrumental in eliminating the pathogenic
threat (1).
The six hyper-variable complementarity-determining regions
(CDRs) of the TCR govern molecular interactions with pMHCI
(2). These CDRs confer the specificity of molecular recognition,
allowing CTLs to attack diseased cells without causing undue harm
to healthy cells (1). Nonetheless, a certain degree of degeneracy
within the antigen recognition system is unavoidable (3). Indeed,
ample experimental evidence supports the notion that a single
TCR clonotype can interact productively with numerous peptide
ligands, which typically vary in their ability to elicit different types
of cellular response (4–14). Furthermore, some cellular responses
are more readily evoked than others (15–18). It seems reasonable
to explain this phenomenon by postulating a hierarchy of thresh-
olds. Such a hierarchy may reside either at the level of individual
TCR/CD3 complexes or at the cellular level. In the former sce-
nario, the threshold parameters relate to distinct components of
the TCR triggering process, with different responses being elicited
at different stages in the development of a mature signalosome.
Essentially, this is the kinetic discrimination model proposed by
Rabinowitz et al. (19), whereby early responses require a shorter
TCR/pMHCI dwell-time than late responses. This model is logi-
cally distinct from the kinetic proofreading model that accounts
for the existence of dwell-time thresholds per se (20).
In the cellular-level scenario, TCR triggering delivers a stereo-
typical signal that elicits distinct responses across a single quantita-
tive gradient (e.g., concentration of the relevant signaling factor).
The contrast between these two scenarios is illustrated diagram-
matically in Figure 1. A third possibility is that the hierarchy
comprises a combination of both receptor-level and cellular-
level modes. It has hitherto been unclear which of these three
alternatives prevails in T-cell signaling.
In this study, we used a mathematical model to investigate the
extent to which each of the three possibilities (receptor-level hier-
archy, cellular-level hierarchy, or a combination of both) agree
with experimental data. Our model accounts for the functional
sensitivity of TCR-mediated responses to a given pMHCI ligand
on the basis of TCR/pMHCI interaction kinetics. The concept
that TCR/pMHCI kinetics governs functional sensitivity was pio-
neered by Lanzavecchia et al. (21) and subsequently formulated
as a mathematical model (22, 23). Bridgeman et al. (24) recently
summarized the available evidence across reported systems.
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FIGURE 1 |Two hypotheses on the level of the response hierarchy. (A)
Signaling cascades are initiated at different points along the TCR/CD3 reaction
pathway, which includes phosphorylation events and the docking of kinases
and linker proteins. Thus, responses R1, R2, and R3 would correspond to
distinct values of the TCR triggering threshold, i.e., T [1]R < T
[2]
R < T
[3]
R . (B)
Cellular integration of signals from the triggered TCRs is shown as a
summation (6) box. This signal passes through a non-linear threshold that
determines whether the cell will respond. Here, R1, R2, and R3 represent
various cellular responses, such as the expression of different cytokine species.
Each receives the same integrated signal W as an input, but different values of
W are required to initiate a response. This is depicted schematically by sigmoid
curves whose midpoint lies to the left, in the middle, or to the right. These
differences correspond to distinct values of the cellular activation threshold,
i.e., W [1]act < W
[2]
act < W
[3]
act . These two hypotheses are not mutually exclusive.
Analysis of TCR/pMHCI interaction kinetics demonstrates that
functional sensitivity is not dependent on a single biophysical
parameter, but rather on the interplay between association rate,
dissociation rate, and ligand densities (23, 25, 26). Under the
experimental conditions prevailing in the present study, however,
the dissociation rate (the reciprocal of the mean dwell-time of
the TCR/pMHCI interaction) emerged as the dominant biophys-
ical parameter. Moreover, we estimated the extent to which the
CD8 coreceptor modulates this parameter using data from par-
allel experiments conducted in the absence of an extracellular
MHCI/CD8 interaction.
Five distinct cellular responses were investigated: (i) mobi-
lization of the degranulation marker CD107a; (ii) secretion of
macrophage inflammatory protein 1-β (MIP-1β); (iii) secretion
of tumor necrosis factor-α (TNF-α); (iv) secretion of interleukin-
2 (IL-2); and (v) secretion of interferon-γ (IFN-γ ). Measured
simultaneously and independently by flow cytometry, the magni-
tude of each response was quantified as a function of fluorescence
and plotted against peptide concentration. The resulting dose-
response curves indicated that the five cellular responses were
elicited by pMHCI stimulation according to a pronounced hierar-
chy. Analysis of these curves by means of the mathematical model,
in conjunction with biophysical data, indicated that the cellular-
level response threshold hierarchy hypothesis provides the most
parsimonious explanation.
MATERIALS AND METHODS
EXPERIMENTAL PROCEDURES
Cells and peptide ligands
The CTL clone ILA1 recognizes residues 540–548 (ILAKFLHWL
in single-letter amino acid code, abbreviated as ILA) of the human
telomerase reverse transcriptase protein presented in the context of
the human MHCI allotype HLA-A∗0201 (HLA-A2). Cell culture
was performed as described previously (27). The altered peptide
ligands used in this study are referred to here as 3G, 5Y, 8T, 8E, and
3G8T; these ligands were largely characterized previously (27, 28),
and display equivalent binding to HLA-A2 (29).
Bioassay
Stable C1R transfectants expressing wild-type HLA-A2 (C1R-
A2) or CD8-null HLA-A2 (C1R-A2null), the α3 domain of
which contains the double mutation D227K/T228A that abro-
gates CD8 binding (30), were pulsed with peptide as indi-
cated for 1 h at 37°C. For each condition, assays were set up
simultaneously in 96-well plates using 4.5× 105 C1R cells per
well, thereby ensuring that all cellular parameters were con-
sistent across ligand stimulations. Subsequently, brefeldin A
(10µg/ml; BD Biosciences) and monensin (0.7µl/ml; BD Bio-
sciences) were added together with a pre-titred concentration of
the directly conjugated monoclonal antibody (mAb) αCD107a-
FITC [BD Pharmingen; Ref. (31)]. Serum-starved CTLs, incu-
bated in Roswell Park Memorial Institute (RPMI) medium (Life
Technologies) containing 2% fetal calf serum (FCS) for 16 h
prior to assay, were subsequently added at 9× 105 cells per
well. After incubation for 6 h, which generally allows sufficient
time for even the most sluggish response to appear, cells were
washed in phosphate-buffered saline (PBS) containing 1% FCS
and incubated for 10 min at room temperature with Aqua fix-
able live/dead cell stain (Life Technologies) to enable the exclu-
sion of dead cells from the analysis. Pre-titred concentrations of
αCD3-H7allophycocyanin (BD Biosciences), αCD8-QD705 (Life
Technologies), and αCD19-V500 (BD Horizon) were then added
for 20 min at 4°C. After two further washes in PBS/1% FCS,
cells were fixed/permeabilized using a Cytofix/Cytoperm™ kit
(BD Biosciences) according to the manufacturer’s instructions,
then stained intracellularly with pre-titred concentrations of
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αMIP-1β-PE (BD Pharmingen), αIFNγ -V450 (BD Horizon),
αIL-2-allophycocyanin (BD Pharmingen), and αTNFα-PECy7
(BD Pharmingen) for 20 min at 4°C.
Flow cytometry
Stained cell samples were acquired and recorded using a cus-
tomized FACS Aria II flow cytometer (BD Biosciences) equipped
for the simultaneous detection of 18 fluorescent parameters. Poly-
chromatic analyses were conducted using FlowJo software version
9.5.2 (TreeStar Inc.). The following gating tree was applied: (i)
single cells were identified based on their light scatter proper-
ties; (ii) Boolean gating was carried out to exclude artifacts and
fluorochrome aggregates; (iii) viable CD3+CD19− events were
selected; (iv) outliers were eliminated in a side-scatter versus CD3
display; and (v) gates were set on cells positive for individual
functional read-outs. The frequencies and median fluorescence
intensity (MFI) values of each functional response were exported
for data analysis to Excel and onward for simultaneous curve fitting
in Mathematica.
Surface plasmon resonance
Soluble TCR, derived from the ILA1 CTL clone, was manufac-
tured as described previously (32, 33). Binding analysis by surface
plasmon resonance (SPR) was performed using a BIAcore T100™
equipped with a CM5 sensor chip (34). Biotinylated pMHCI (200–
400 response units) was immobilized to streptavidin, which was
chemically linked to the chip surface. The pMHCI was injected at
a slow flow rate (10µl/min) to ensure uniform distribution on the
chip surface. Combined with the small amount of pMHCI bound
to the chip surface, this reduced the likelihood of dissociation rate
limiting mass transfer effects. The ILA1 TCR was purified and con-
centrated to ∼100µM on the day of SPR analysis to reduce the
likelihood of TCR aggregation affecting the results. At least 5 serial
dilutions were prepared in duplicate and injected over the relevant
sensor chips at a flow rate of 45µl/min. All experiments were con-
ducted at 25°C. Results were analyzed using BIAevaluation, Excel,
and Origin.
THEORY AND DATA ANALYSIS
Assumptions
The assumptions of the TCR triggering model are as follows: (i)
TCRs on the T-cell surface become “triggered” (i.e., are induced to
become signalosomes) during an interaction with a pMHCI lig-
and; and (ii) the T-cell accumulates the signals emanating from
triggered TCRs over space (cell:cell interface) and time (dura-
tion of cell:cell interaction), proceeding with a response when this
signal exceeds a cellular activation threshold. The mathematical
formulation of these assumptions is based on the kinetics of the
TCR/pMHCI interaction.
The TCR triggering rate equation
The model describes the kinetics of interactions between TCR
and pMHCI molecules in the interface area between a T-cell and
an antigen-presenting cell (APC). This area is occupied by TCRs
on the T-cell side of the interaction and by pMHCI complexes
on the APC side. Let RT be the total number of TCRs and ZT
be the total number of pMHCI molecules. Both are subject to a
conservation law:
RT = C + R (1)
ZT = C + Z (2)
where C is the number of TCR/pMHCI complexes, R is the
number of TCRs not engaged in a complex (i.e., “free” TCR mol-
ecules) and Z is the number of free pMHCI molecules. Kinetic
equilibrium is expressed by the law of mass action equation:
konRZ = koff C . (3)
This equation, together with equations (1) and (2), leads to a
quadratic in C with solution
C = RT + ZT + koff /kon
2
(
1−
√
1− 4RT ZT
RT + ZT + koff /kon
)
(4)
(the other root is irrelevant since it exceeds both RT and ZT). The
rate at which TCRs are being triggered can be expressed as the
rate at which TCR/pMHCI complexes dissociate times the prob-
ability that any given TCR/pMHCI association event results in a
triggering of the associated TCR/CD3 complex:
W = koff C Ptrig (5)
where W denotes the TCR triggering rate and P trig the triggering
probability for an individual interaction event. Since triggering
of a TCR/CD3 complex requires completion of a series of phos-
phorylation and docking events, it is reasonable to assume that
triggering can only happen if the peptide ligand remains engaged
for at least a certain amount of time. This minimum duration is
the TCR triggering threshold TR. If the lifetime of the TCR/pMHCI
complex is exponentially distributed, the triggering probability is
given by:
Ptrig = exp{−koff TR}. (6)
Combined, equations (4–6) yield the general triggering rate
equation:
W = koff exp{−koff TR}
2
(RT + ZT + koff /kon)
×
(
1−
√
1− 4RT ZT
RT + ZT + koff /kon
)
. (7)
Simple forms in special cases [equations (13–15)] are obtained
by using the first-order approximation to the square root in
equation (7).
Connecting the theoretical model to experimental observations
The available data comprise cellular response measurements
(read-outs) of T-cell activation following exposure to APCs incu-
bated with various peptide ligands across a range of concen-
trations, as well as TCR/pMHCI association and dissociation
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rates for each peptide ligand, measured via SPR. To relate these
measurements to the TCR triggering theory, a number of auxiliary
assumptions are required. In particular, if Y is the peptide incu-
bation concentration, the following proportionality is assumed:
ZT = αY . (8)
If KD is the dissociation constant determined via SPR, the
following proportionality is assumed:
koff
kon
= κKD . (9)
The proportionality constant κ is required to convert rates
as measured via SPR to the 2-dimensional environment of the
cell:cell interaction area. To connect the model to data, two com-
pound parameters are introduced: ζ =α/κ (dimensionless), and
ρ=RT/κ (M). With these parameters, the TCR triggering rate
w =W /κ (in M·s−1) assumes a simpler form:
w = koff exp{−koff TR}
2
(ρ + ζY + KD)
×
(
1−
√
1− 4ρζY
ρ + ζY + KD
)
. (10)
The read-out in the present study is median fluorescence inten-
sity (MFI), which is a valid measure of activation in view of its
good correlation with the fraction of responding cells. Accord-
ingly, the read-out U is assumed to be proportional to the fraction
of responding cells. This assumption is validated by response data
at the level of individual cells (see Results below). The equation
for the read-out is as follows:
U = Umin + (Umax − Umin)P(respond) (11)
where U min and U max are nuisance parameters associated with
the read-out procedure; these parameters take specific values for
each type of cellular response and are assumed not to vary across
peptide ligands. The probability that a T-cell responds is modeled
as follows:
P(respond) = P(wact ≤ w) (12)
where w is the scaled TCR triggering rate given by equation (10)
and wact is the cellular activation threshold. This latter quantity is
assumed to have a log-normal distribution over the population
of T-cells in the experiment. Stochastic variation between the T-
cells within the responding population is thus taken into account.
The parameters are estimated by simultaneous least-squares fit-
ting over the set of available ligands and read-outs. The median of
the log-normal distribution provides the estimate of wact.
Implementation of response hierarchy hypotheses
We examined five different cellular responses and compared three
hypotheses: (i) for each type of cellular response, both TR and
wact have distinct values; (ii) there is a common value of TR across
responses, whereas wact has a different value for each response; and
(iii) there is a common value of wact across responses, whereas
TR has a different value for each response. As the least-squares
fit is carried out simultaneously, these hypotheses can be imple-
mented by specifying either common or particular values for these
parameters.
RESULTS
KINETIC PARAMETERS AND LIGAND NUMBERS INTERACT TO
DETERMINE THE RATE OF TCR TRIGGERING
The triggering equation (7) reduces to various simplified forms,
depending on which receptors are kinetically limiting. These forms
are of immunological interest since they illuminate the controversy
over which kinetic parameter primarily governs T-cell activation.
First, if the term koff/kon is much larger than both RT and ZT,
which applies when both cells have introduced comparatively
low numbers of ligands into the interaction area, the following
approximation is accurate:
W = RT ZT kon exp{−koff TR} (koff /kon  max{RT , ZT }) ,
(13)
that is, the triggering rate will be proportional to both TCR and
pMHCI numbers: signaling is affinity-limited.
On the other hand, if the cells express numbers of lig-
ands in the interaction area that are much larger than the 2-
dimensional dissociation constant koff/kon, there are two further
good approximations:
W = RT koff exp{−koff TR} (koff /kon  ZT ) (14)
W = ZT koff exp{−koff TR} (koff /kon  RT ); (15)
in the first case, signaling is TCR-limited and in the second, it
is MHC-limited. These equations imply that under the receptor-
limited regimes, the TCR triggering rate displays an optimum
relative to koff at the point koff = T−1R , whereas under the affinity-
limited regime, W increases monotonically in kon and decreases
monotonically in koff .
When both RT and ZT are much larger than koff/kon, the
TCR triggering rate is proportional to min{RT, ZT} as shown in
Figure 2A, whereas at lower receptor densities, W ∝RTZT as per
equation (13). The transition between the two regimes happens
where the receptor densities traverse the 2-dimensional dissoci-
ation constant koff/kon. Thus, depending on receptor densities,
the triggering rate may be affected solely by changes in RT (TCR
copy numbers), ZT (pMHCI copy numbers), or both. The MHC-
limited case corresponds to the serial triggering (serial engage-
ment) hypothesis proposed by Valitutti et al. (35–37); however,
the present theory is more general in the sense that the serial
triggering mechanism arises as a special case.
Figure 2B shows that the TCR triggering rate increases with
both kon and mean dwell-time k
−1
off when kon is low (relative to
receptor densities; scaling is explained in the legend to Figure 2).
However, when kon increases, the triggering rate exhibits a weak
dependence on kon and a non-monotone dependence on koff ,
attaining a maximum at koff = 1/TR.
The avidity effect is routinely exploited to determine the func-
tional sensitivity of the TCR to a given ligand. This effect hinges
on mutual compensation by pMHC ligand numbers and the TCR
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FIGURE 2 |TCR triggering rate depends onTCR/pMHCI association and
dissociation rates as well as the densities ofTCR and pMHCI molecules.
(A) Dependence of the rate of TCR triggering on receptor densities.
Quantities are dimensionless: TCR triggering rate is scaled as WT 2R kon, TCR
density is scaled as RTk on/k off, pMHCI density is scaled as ZTk on/k off, and
k off =1/TR is assumed (this means that the ligand is optimal under
MHC-limited conditions). (B) Dependence of the rate of TCR triggering on
kinetic parameters. The dependence on the mean TCR/pMHCI interaction
time (1/k off) is non-monotone, indicating that a maximally strong agonist
must satisfy k off = 1/TR. In contrast, the dependence on k on is monotone.
Affinity is customarily expressed by the dissociation constant KD = k off/k on.
Accordingly, whether or not an improvement of affinity correlates with an
enhanced TCR triggering rate depends on where the system is initially
located on the surface of the graph, as well as on the relative contributions
that changes in association and dissociation rates make to the overall change
in affinity. Quantities are dimensionless: TCR triggering rate is scaled as
WTR/(RT + ZT), association rate is scaled as k onTR(RT +ZT), and the mean
lifetime of the interaction is scaled as 1/(k offTR). Here, RT =ZT. Similar
qualitative behavior results when the two ligand densities are unequal.
triggering rate per ligand; i.e., a T-cell can be activated by a strong
agonist even at low copy numbers whereas a poor agonist may be
effective but only at sufficiently high copy numbers. In equation
(15), copy numbers are expressed by ZT and the intrinsic quality
of the ligand is expressed by the quantity koffexp{−koffTR}. The
latter attains a maximum at koff = 1/TR. If the triggering rate W
needs to exceed a certain threshold value to activate the T-cell, suf-
ficient pMHCI copy numbers can compensate for a suboptimal
intrinsic triggering rate. However, increasing ZT may transfer the
system into the TCR-limited regime (Figure 2B),under which con-
ditions pMHCI density-based compensation cannot be achieved,
cf. equation (14). Moreover, physiological bounds must exist on
how many copies can be present in the interaction area and poor
agonists will be unable to activate the T-cell unless unusually high
numbers of the ligand are presented (e.g., the cell transcribes very
large quantities of the protein).
INTERCELLULAR VARIATION IN RESPONSE HIERARCHY THRESHOLDS
An overview of the experimental data is provided in Figure 3. In
keeping with the avidity effect, the fraction of cells that exhibited at
least n distinct responses (where 1≤ n≤ 5) increased with peptide
concentration; individual ligands differed with respect to the min-
imal concentration required to elicit n cellular responses. There
was appreciable variability with regard to which functions were
elicited, as depicted in Figure 3B, which displays the data obtained
at peptide concentrations of 10−6 M. The responses generally
conformed to the following series:
MIP-1β < CD107a < TNFα < IL-2 < IFN-γ
(with the lowest threshold on the left). However, a small propor-
tion of cells exhibited a slightly different ordering of threshold
values, as would be expected given the natural variability between
cells with respect to the threshold value of any one given response.
These results indicate that, for each response, there is varia-
tion between cells with respect to the cellular threshold value. This
supports the assumption made in the section Connecting the the-
oretical model to experimental observations above, namely that the
sigmoid dose-response shape of the population-level read-out can
be accounted for by postulating a statistical distribution at the cell
population level with respect to the cellular threshold for any given
response.
THE RESPONSE HIERARCHY RESIDES AT THE LEVEL OF CELLULAR
SIGNAL INTEGRATION
The parameters of the mathematical model were estimated by
means of least-squares fitting of model predictions to the data; the
biophysical data are summarized in Table 1 and Figure A1 in the
Appendix. Figure 4 shows the results of least-squares curve fit-
ting for the dual-hierarchy hypothesis, the receptor-level response
hierarchy hypothesis, and the cellular-level response hierarchy
hypothesis. The goodness-of-fit should be assessed in the light
of the parsimoniousness of the model. There is less than one para-
meter per curve. This compares favorably to the standard practice
of fitting a separate sigmoid model to each curve, which requires
three or more parameters per curve. The fit is very good for such
extreme parameter-count efficiency.
There is no substantial difference in the quality of fit between
the dual-threshold model and the cellular-threshold model,
whereas the fit to the receptor-threshold model is consistently less
good. Thus, the data are best explained by postulating a hierarchy
only at the level of the cellular activation threshold.
The MIP-1β response was found to have the lowest acti-
vation threshold. Relative to this value, the ratios of median
threshold values were found to be as follows: CD107a/MIP-
1β = 1.44; TNFα/MIP-1β = 11.7; IL-2/MIP-1β = 225; and IFN-
γ /MIP-1β = 231. These findings broadly agree with the consensus
series derived from the data reported in Figure 3. The esti-
mated median activation threshold values are markedly higher
for IL-2 and IFN-γ , which required a stimulus over two orders of
magnitude larger compared to the more readily elicited responses.
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FIGURE 3 | Functional variation at the cell population level in
response to six different peptide ligands. The CTL clone ILA1 was
stimulated for 6 h with peptide-pulsed C1R-A2 targets as indicated. Five
functional read-outs (CD107a, MIP-1β, TNF-α, IL-2, and IFN-γ ) were
measured via flow cytometry. The 8E peptide was included as an
extremely weak ligand. (A) Overview of functional profiles. Pie chart
segments represent the fraction of cells expressing the number of
functions indicated in the key. (B) Detailed analysis of functional profiles at
[peptide]=10−6 M. Pie charts are extended with arcs defining expressed
functions as indicated in the key.
Table 1 | Biophysical parameters.
Ligand On-rate (M−1s−1) Off-rate (s−1) KD (M)
3G8T 19,500 0.049 2.5×10−6
3G 16,000 0.047 2.9×10−6
8T 4,000 0.095 2.4×10−5
ILA 4,100 0.13 3.2×10−5
5Y 1,300 0.32 2.5×10−4
The kinetics of the TCR/pMHCI interaction for the 5Y and 3G8T ligands are
reported here for the first time; it should be noted that the 5Y data are subject to
a comparatively greater potential measurement error due to their rapidity.
MHCI/CD8 BINDING MODULATES FUNCTIONAL SENSITIVITY
The experiments described above were repeated using C1R-A2null
cells as APCs, which cannot productively engage the CD8 corecep-
tor (38). It is well-attested that the MHCI/CD8 interaction mod-
ulates the TCR/pMHCI association rate (kon), the TCR/pMHCI
dissociation rate (koff), and the receptor-level triggering threshold
(TR) (27, 38, 39). Multipliers can be used to model these effects.
For example, koff is replaced throughout by γoffkoff where γoff rep-
resents the effect of abrogating the MHCI/CD8 interaction and
γoff > 1 since CD8 stabilizes the TCR/pMHCI interaction (38–
40). The parameter γoff was set to 2.16, the value reported by
Wooldridge et al. (38).
Since the prevailing kinetic regime in the experiments described
here is MHC limitation, the parameter γ on for the association rate
could not be estimated and was set to 1. This leaves a single free
parameter, γ R, for the data obtained with C1R-A2null APCs. Data
fits are shown in Figure 5, with γ R= 1.14 (the least-squares esti-
mate) for the receptor threshold TR. This value indicates that the
MHCI/CD8 interaction decreases the TCR triggering threshold
by 13%.
DISCUSSION
T-cells can exhibit a variety of cellular responses to TCR-mediated
stimulation, some of which are elicited far more readily than
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cellular-level threshold model in which the cellular activation thresholds have
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FIGURE 5 | Dose-response curves for five peptide ligands and five
cellular responses in the absence of the MHCI/CD8 interaction. All curves
correspond to the cellular-level threshold model in which the cellular activation
thresholds have different values for different cellular responses, but the
receptor-level threshold is constant. Black curves are the fits to the data
shown. Gray curves correspond to the situation in which the MHCI/CD8
interaction is present. Parameter values are as in the previous figure. Two new
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the absence of the CD8 effect; γ off was set to 2.16 and γ R was estimated as
the sole remaining free parameter.
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others. In particular, different responses require different levels of
stimulation in terms of ligand densities present on the APC sur-
face. Such threshold differences might be postulated at the receptor
level (different response pathways branch off at different stages in
the sequence of signaling events), and/or at the cellular level (the
TCR signal received by the T-cell needs to exceed different thresh-
old values for different responses). The present study suggests that
the cellular-level hypothesis is the most parsimonious explanation
consistent with the data. Furthermore, the role of the CD8 core-
ceptor as a modulator of T-cell functional sensitivity is confirmed
by the present findings, which indicate that the MHCI/CD8 inter-
action decreases the TCR/pMHCI dissociation rate as well as the
duration of TCR/pMHCI contact required to activate the T-cell.
A key consideration for the interpretation of our results is the
standardized nature of the system. Determinative cellular factors,
such as TCR density, membrane constituency, and the expression
of costimulatory/inhibitory molecules, were fixed across all condi-
tions, which means that these extraneous factors can be discounted
as discriminative because only ligand nature and concentration
varied between stimulations. These built-in controls justify the
simplifying assumptions from which the mathematical model was
derived.
The present findings certainly do not exclude the existence of a
receptor-level hierarchy. Indeed, the co-existence of hierarchies at
both the receptor and cellular levels may explain the data equally
well. However, the hypothesis that the response hierarchy resides
solely at the receptor level is contradicted by the present findings. A
threshold hierarchy at the level of cellular activation would imply
that the functional responses are located downstream from signal-
ing pathways that share a common starting point (the triggered
TCR or signalosome). Further detailed molecular studies of the
CD3-complex phosphorylation cascade would be required to rule
out a receptor-level hierarchy definitively.
Our mathematical model elucidates the contrasting roles played
by the dissociation rate and the affinity constant as determinants
of T-cell functional sensitivity, with TCR and pMHCI molecular
densities governing the limitation regime under which the kinetics
operate. The disappearance of the optimum behavior as the sys-
tem moves from the receptor-limited to the affinity-limited regime
can be studied experimentally by increasing TCR density. This
shift was first predicted by Van den Berg et al. (23) and confirmed
experimentally by Gonzales et al. (41). Furthermore, the pattern
of dependence on kon and koff shown in Figure 2B may account
for the discrepancies between the findings of Kalergis et al. (42),
who reported such an optimal dwell-time (= k−1off ), and the find-
ings of Holler et al. (43), who reported monotone dependence.
The shift along the kon axis may also explain the observations of
Irving et al. (26), who observed that affinity modulates the depen-
dence on koff . In the experimental system studied here, the TCR
is stimulated under MHC-limited conditions. This means that
the optimum-type dependence on koff prevails. This is shown in
Figure 6, where the calculated TCR triggering rate (at 10−5 M) is
plotted against koff . The effect of kon is so slight that the curves
overlap almost perfectly for the five ligands. Even under MHC-
limited conditions, however, kon remains a crucial determinant
of functional sensitivity, in view of the fact that the ratio of koff
and kon determines the transition between affinity-limited and
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FIGURE 6 | Differential effects of CD8 modulation on functional
sensitivity. TCR triggering rate, scaled with respect to the optimal ligand
under MHC-limited conditions, as a function of k off, comparing the wild-type
MHCI/CD8 interaction (“A2”) to the abrogated MHCI/CD8 interaction
(“A2null”). The positions for the five ligands are indicated. The inset shows
two hypothetical ligands: “X,” which is unaffected by the absence of the
CD8 interaction, and “Y,” which is optimal under the MHC-null condition.
ligand-limited signaling, as illustrated schematically in Figure 7.
Thus, the association rate and the dissociation rate play distinct
roles in T-cell activation, consistent with reports of dominant
effects associated with each of these biophysical parameters under
different conditions (24, 44); these differences also explain earlier
observations on the interplay of kinetic parameters and receptor
numbers (41, 45, 46).
In the presence of the wild-type MHCI/CD8 interaction, the
ligands 3G and 3G8T are virtually optimal, whereas abrogation of
MHCI/CD8 binding leads to a reduction in functional sensitivity.
In virtue of the non-linear character of the curve, the magnitude
of the reduction varies considerably across ligands. Two parame-
ters (γ on and γ R) suffice to capture these effects. The ILA ligand
evokes a triggering rate approximately one order of magnitude
less than optimal under C1R-A2null conditions. Nonetheless, the
data show that strongly attenuated but discernible responses can
be elicited at sufficiently high presentation levels, in keeping with
Wooldridge et al. (14), who reported that a ligand could be physio-
logically significant even at an estimated∼2.1 orders of magnitude
below the optimal ligand for a responding T-cell clone.
Although all ligands studied here become less potent when
presented by C1R-A2null cells, the model predicts that this is
not necessarily the case. Indeed, the functional sensitivity to a
ligand marked “X” in the inset of Figure 6 is unaffected when
the MHCI/CD8 interaction is abrogated. Moreover, ligand “Y”
becomes optimal in the absence of the CD8 effect (so that the T-cell
has a higher functional sensitivity to this ligand under CD8-null
conditions). The existence of such ligands would imply that T-cells
can “tune” to distinct cognate ligands by up- or down-regulating
their CD8 coreceptors. This effect would greatly amplify the ability
of T-cells to reconcile extensive cross-reactivity with the avoidance
of self-recognition.
The hypothetical ligands “X” and “Y” are strongly hetero-
clitic. Peptides of this nature occur markedly less frequently than
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A
B
C
FIGURE 7 | Interplay between kinetic parameters and receptor
densities. (A) Affinity-limited: the TCR triggering rate is proportional to the
densities of both receptors. (B) TCR-limited: the TCR triggering rate is
proportional to the TCR density and is monotone decreasing in k off. (C)
MHC-limited: the TCR triggering rate is proportional to the MHC density
and has an optimum k off. The affinity KD = k off/k on governs the transitions
between these kinetic regimes.
homoclitic ligands, which makes them more challenging to detect
and characterize. Nonetheless, work is ongoing to demonstrate the
existence of such anomalous ligands, using combinatorial peptide
library screening combined with importance sampling (14) in the
presence of different extracellular contributions from the CD8
coreceptor (29).
The effect of CD8 on the value of the TCR triggering thresh-
old is consistent with the conclusions of Van den Berg et al. (39)
and may be due to the association of TCR/CD3 with protein tyro-
sine kinases such as p56lck, which expedites the immunoglobulin
family tyrosine-based activation motif phosphorylation sequence
(47). This agrees with the observation that the CD8 αβ hetero-
dimer is more potent as a coreceptor than the αα homo-dimer
(48, 49), perhaps due to interactions with other signalosome
components mediated by the palmitoylated CD8 β chain (50),
which interacts with myristoylated p56lck. Docking of CD8 to
the TCR/CD3 complex may also be driven by initial activation
(51). The kinetics of CD8 binding after TCR/pMHC contact
was analyzed previously by Van den Berg and Sewell (52). More
recently, Mukhopadhyay et al. (53) developed a model that explic-
itly accounts for the interplay between the CD3 phosphorylation
cascade and p56lck, ZAP-70, and CD45.
The dissociation rates determined by SPR were assumed to be
indicative of the normal interaction in this study. In reality, these
values might be more true to the case where the MHCI/CD8 inter-
action is absent. Assuming the latter would not dramatically alter
the qualitative conclusions of this study, but would lead to a slight
adjustment in the interpretation of the parameter estimates. Most
importantly, the value found for the TCR triggering threshold TR
would be adjusted down from 17.46 to 15.26 s.
Values based on SPR experiments are best regarded as 3-
dimensional, representative of ligands in solution. However, the
TCR/pMHCI interaction takes place in a 2-dimensional envi-
ronment, which essentially reduces spatial degrees of freedom of
molecular motion and introduces dynamics related to the forces
that constrain the molecules to this environment (54). Conse-
quently, rate constants may be different in two dimensions as
opposed to three dimensions. In particular, 2-dimensional dis-
sociation rates can be substantially faster (55). The ratio between
the 3-dimensional and 2-dimensional affinities is a length mea-
sure, denoted h and called the confinement length (56, 57). Wu
et al. demonstrated that h is proportional to the range of motion
available to the free forms of the interacting ligands along the
spatial axis perpendicular to the two parallel membranes. Thus,
the intermembrane separation provides an upper bound, and if
the ranges of motion do not differ too much, it is reasonable to
assume that the confinement length is roughly the same for all
mutants involved.
The use of a fixed receptor duration might appear simplistic
given the complexity of the events that are required to trigger a
TCR/CD3 complex, but the law of large numbers provides indi-
rect support for a simple assumption: the true waiting-time-till-
triggering is a composite of a large number of stochastic durations
which tends to regress it on the mean value. In fact, the number of
terms is itself a random variate due to the possibility of alternative
routes in the activation pathway of the complex (such processes
are termed “compound stochastic”). The complexity illustrated in
Figure 1 effectively underpins a simple assumption, viz. that there
is a fixed, stereotypical receptor threshold TR.
The parameters TR and wact are both subject to further modula-
tion. By varying the levels of the CD8 coreceptor, surface molecules
such as CD45, and cytosolic concentrations of kinases, phospho-
rylases, and linker proteins in the immediate vicinity of the CD3
complex, the T-cell can adjust the effective value of the recep-
tor triggering threshold TR (29, 30, 38, 39, 58–61). The value of
the cellular activation threshold wact is modulated by costimu-
lation (“signal 2”). Moreover, the T-cell can actively modulate
its receptiveness to this signal by adjusting the relative levels of
CD28 and CD152 (52, 62). Furthermore, the maintenance of tol-
erance requires continual dynamic tuning of the cellular activation
threshold (63, 64). Conceivably, these mechanisms provide an
additional “multiplier” that modulates wact over and above the
factors that set wact to different values for different responses.
The data on intercellular response variability (Figure 3) sup-
port the assumption that the distribution of responsiveness in
terms of MFI can be attributed to intercellular variation in the
triggering threshold. However, the observed variability may also
arise from differences in the numbers of TCR and pMHCI mole-
cules present in the T-cell/APC interaction area. Mathematically,
this model is slightly more involved because interactions can now
be distributed over different kinetic regimes. Nonetheless, apart
from this technical difficulty, the resulting model is mathemati-
cally equivalent; this follows from the properties of the log-normal
distribution. Thus, the analysis is not substantially affected by this
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alternative explanation of the intercellular variability. Experimen-
tally, the two hypotheses could be distinguished by following an
individual T-cell over a series of interactions and responses. If cel-
lular thresholds for the various responses remain largely constant,
there would be little event-to-event variation according to the for-
mer hypothesis; in contrast, the receptor copy number hypothesis
would predict considerable event-to-event variation.
In addition, there may be variability with respect to antigen
presentation levels across the experimental APC population, due
to differential antigen exposure and stochastic effects in anti-
gen acceptance from the incubation medium. However, it can
be shown that the resulting variance is not such as to make
a substantial contribution to overall variability, for instance by
following the argument presented in Appendix C of Van den
Berg et al. (22).
When the TCR/pMHCI ternary complex dissociates, the cova-
lent modifications and multimeric aggregations that the CD3
complex undergoes during the gradual transition to signalosome
status are reversed, both by thermal agitation and the action of
phosphorylases. In the present model, it has been assumed that this
“reset” occurs much more rapidly than the typical time required
for the TCR/CD3 complex to encounter the next non-null pMHCI
ligand. However, given that the molecules have to drift away from
each other through diffusion in the 2-dimensional arena of the T-
cell/APC interface, there is a possibility of rapid rebinding to the
same pMHCI molecule before the CD3 complex has had sufficient
time to “reset.” This rapid rebinding is equivalent to a diminish-
ment of the effective off-rate; a basic model capturing this effect
has been proposed by Aleksic et al. (65). Extending the present
model with this effect is straightforward in principle, albeit at the
cost of an additional parameter. Furthermore, the number of com-
plexes with other pMHCI species is ignored in equation (1). This
is valid if the vast majority of all other ligands consists of null
agonists. An analysis that takes the entire presentation profile (all
pMHCI species present) into account can be found in Van den
Berg et al. (22, 23).
A further aspect of the cellular activation threshold that has
been left implicit in the present treatment is the duration of the
T-cell/APC interaction. If this contact is initiated at t 0 and is ter-
minated at t 1, the cumulative signal transmitted to the cytosolic
signaling machinery is given by an integral:
Q =
∫ t1
t0
W (τ )dτ . (16)
In fact, this quantity Q is presumed to be directly compared to
a threshold. However, Q/(t 1− t 0) is proportional to the activation
threshold as defined in the present study. Indeed, variability in the
duration of the contact is one of the sources of stochasticity under-
lying the log-normal response curve used to fit the dose-response
curves.
A related phenomenon is that of TCR down-regulation (66–
68), whereby triggered TCRs are gradually removed from the cell
surface. This affects the integral in equation (16); Van den Berg et
al. (23) discuss how the model can be extended to take this effect
into account. TCR down-regulation can in fact be exploited by the
T-cell to gauge both kon and koff independently. As indicated in
Figure 2A, if the system starts in the MHC-limited regime, grad-
ual removal of TCR molecules will result in a transition to the
TCR-limited regime, where a sudden drop of the instantaneous
signal results. At the point of change-over, RT≈ZT. This means
that the T-cell can, in principle, glean a rough estimate of the bio-
physical rate parameters koff and kon by combining information
from the gross signal and the number of down-regulated TCRs
at the transition point. This mechanism can only function in the
ligand-limited regime, not in the affinity-limited regime.
In conclusion, the present study confirms that a response hier-
archy exists with respect to the strength of TCR stimulation
required to elicit various cellular responses. Moreover, a combi-
nation of experimentation and mathematical modeling indicates
that this hierarchy resides at the cellular level rather than at the
level of the individual receptor molecules. Functional sensitivity
is generally enhanced by the CD8 coreceptor, although the the-
ory indicates that the MHCI/CD8 interaction can depress TCR
signaling for certain heteroclitic ligands.
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FIGURE A1 | Kinetic measurements of ILA1TCR interactions with the
agonist pMHCI ligand 3G8T. SPR kinetic measurements were performed
with five serial twofold dilutions of the ILA1 TCR, starting at 50µM, flowed
over immobilized 3G8T/HLA-A2 complexes. Injections were performed in
duplicate for each TCR concentration. The plots show data (thin lines) and
curve fitting (thick lines) representative of two separate experiments.
First-order exponential association rate (k on) and dissociation rate (k off) were
fitted simultaneously by least squares. Values for k on, k off, and KD are shown
inTable 1.
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